Attached files
file | filename |
---|---|
10-K - FORM 10-K - CytoDyn Inc. | d395273d10k.htm |
EX-31.2 - EX-31.2 - CytoDyn Inc. | d395273dex312.htm |
EX-31.1 - EX-31.1 - CytoDyn Inc. | d395273dex311.htm |
EX-24 - EX-24 - CytoDyn Inc. | d395273dex24.htm |
EX-23 - EX-23 - CytoDyn Inc. | d395273dex23.htm |
EX-10.7 - EX-10.7 - CytoDyn Inc. | d395273dex107.htm |
EX-4.11 - EX-4.11 - CytoDyn Inc. | d395273dex411.htm |
EX-4.10 - EX-4.10 - CytoDyn Inc. | d395273dex410.htm |
Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
In connection with the Annual Report of CytoDyn Inc. (the Company) on Form 10-K for the year ended May 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned certify, pursuant to 18 U.S.C. § 1350, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Nader Z. Pourhassan | /s/ Michael D. Mulholland | |||
Nader Z. Pourhassan, Ph. D. President and Chief Executive Officer July 19, 2017 |
Michael D. Mulholland Chief Financial Officer July 19, 2017 |
A signed original of this written statement required by Section 906 has been provided to CytoDyn Inc. and will be retained by CytoDyn Inc. and furnished to the Securities and Exchange Commission or its staff upon request.